Cardiff Oncology (CRDF) Operating Leases (2019 - 2025)
Historic Operating Leases for Cardiff Oncology (CRDF) over the last 7 years, with Q3 2025 value amounting to $284000.0.
- Cardiff Oncology's Operating Leases fell 7099.08% to $284000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $284000.0, marking a year-over-year decrease of 7099.08%. This contributed to the annual value of $813000.0 for FY2024, which is 4423.87% down from last year.
- Cardiff Oncology's Operating Leases amounted to $284000.0 in Q3 2025, which was down 7099.08% from $464000.0 recorded in Q2 2025.
- Cardiff Oncology's Operating Leases' 5-year high stood at $3.3 million during Q3 2021, with a 5-year trough of $284000.0 in Q3 2025.
- For the 5-year period, Cardiff Oncology's Operating Leases averaged around $1.7 million, with its median value being $1.5 million (2023).
- Per our database at Business Quant, Cardiff Oncology's Operating Leases skyrocketed by 62941.18% in 2022 and then plummeted by 7099.08% in 2025.
- Over the past 5 years, Cardiff Oncology's Operating Leases (Quarter) stood at $3.1 million in 2021, then fell by 12.95% to $2.7 million in 2022, then tumbled by 46.3% to $1.5 million in 2023, then tumbled by 44.24% to $813000.0 in 2024, then tumbled by 65.07% to $284000.0 in 2025.
- Its Operating Leases was $284000.0 in Q3 2025, compared to $464000.0 in Q2 2025 and $640000.0 in Q1 2025.